FIELD: biotechnology. SUBSTANCE: using plasmid pVAX2 consisting of vector pVAR15 and gene encoding hepatitis B virus surface antigen (S-gene) the latter is transferred in genome of variolovaccine virus genome - a variant of Lister-LIVP strain showing low neurovirulence for rabbit and mouse and approved at the large range in human (strain is grafted to more than 1.5 mlrd men). Prepared recombinant LIOGEN-HB/C2-ТК- induces HBsAg in infected cells and shows tk--phenotype. Thymidine kinase gene of simple virus (I) is inserted in Hind III-fragment of recombinant LIOGEN-HB/C2-tk+ for recovery of ТК--phenotype, and recombinant of LIOGEN-HB/C2-ТК+ is prepared. EFFECT: preparing of recombinant variolovaccine virus. 3 cl
Authors
Dates
1995-02-27—Published
1985-08-20—Filed